SMN-independent approaches for spinal muscular atrophy
Mechanisms and SMN-Independent Therapies for Spinal Muscular Atrophy
This project looks for new treatments for people with spinal muscular atrophy that work without relying only on restoring the SMN protein.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11307153 on NIH RePORTER |
What this research studies
This project studies why low SMN protein harms the nerves and muscles that control movement and tests therapies that do not depend on boosting SMN. Researchers use laboratory models, molecular studies, and gene-delivery tools such as AAV vectors to target other pathways that keep motor neurons and muscle healthy. The team aims to find treatments that could protect or restore function even in patients who do not fully respond to current SMN-focused drugs. Promising leads would be used to design future human studies and clinical trials.
Who could benefit from this research
Good fit: People with spinal muscular atrophy—especially infants, young children, or patients who have not fully responded to SMN-targeting therapies—would be the main focus for eventual clinical testing.
Not a fit: Patients with neurological conditions unrelated to SMA or those with very advanced, irreversible nerve and muscle damage are unlikely to benefit from the therapies under study.
Why it matters
Potential benefit: Could produce new treatments that help people with SMA, including those who gain limited benefit from current SMN-centered therapies.
How similar studies have performed: SMN-replacement therapies like Spinraza and AAV-based gene therapy have benefited many patients, but SMN-independent strategies are newer and less proven.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Monani, Umrao — Columbia University Health Sciences
- Study coordinator: Monani, Umrao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.